Clinical Pharmacology Reviewer
US Food and Drug Administration
Dr. Sojeong Yi, PhD, is a senior clinical pharmacology reviewer in Division of Inflammation and Immune Pharmacology in the Office of Clinical Pharmacology at the FDA. Since 2016, she has been working on IND and NDA/BLA submissions to support regulatory decisions from a clinical pharmacology perspective representing clinical pharmacology in multi-disciplinary review teams in various therapeutic areas (gastroenterology, hepatology, inborn error diseases, dermatology, pulmonology, rheumatology, ophthalmology). She majored in Pharmacy at Ewha Women’s University in Korea, and earned her MS and PhD in Clinical Pharmacology from Seoul National University in Korea. Subsequently, she worked as a clinical fellow in Dong-A University Hospital, subsequently as a research fellow in Seoul National University College of Medicine, for 2 years each. She has broad and intensive research experiences in clinical pharmacology studies in clinical drug development as well as pharmacogenomics and pharmacometrics.